Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma

被引:152
作者
Gomez, Dhanwant [1 ]
Morris-Stiff, Gareth [1 ]
Toogood, Giles J. [1 ]
Lodge, J. Peter A. [1 ]
Prasad, K. Rajendra [1 ]
机构
[1] St James Univ Hosp, Leeds Teaching Hosp NHS Trust, Hepatobiliary & Transplantat Unit, Leeds LS9 7TF, W Yorkshire, England
关键词
cholangiocarcinoma; intrahepatic; disease-free; survival; resection;
D O I
10.1002/jso.21001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: To analyse the results and prognostic factors affecting disease-free and overall survival following potentially curative resection for intrahepatic cholangiocarcinoma (IHCC). Methods: Patients undergoing resection for IHCC from January 1996 to December 2006 were included. Data analysed included demographics, clinical and histopathology data. Results: Twenty-seven patients were identified with a median age of 57 (32-84) years. The 1-, 3- and 5-year overall and disease-free survival rates were 74%, 16% and 16%, and 44%, 15% and 15%, respectively. On univariate analysis, age <65 years, female gender, neutrophil to lymphocyte ratio (NLR) >= 5, micro-vascular invasion and lymph node involvement were predictors of poorer overall survival. Multivariate analysis did not identify any independent predictors of overall survival. A NLR >= 5 was the only adverse predictor of disease-free survival. The median disease-free survival of patients with NLR >= 5 was 6 months compared to 18 months for those with NLR < 5. There was a significant association between patients with a NLR >= 5 and larger turnout size, satellite lesions, micro-vascular invasion and lymph node involvement. Conclusion: Long-term outcome following resection of IHCC is poor. A pre-operative NLR >= 5 was an adverse predictor of disease-free survival and was associated with an aggressive tumour biology profile.
引用
收藏
页码:513 / 518
页数:6
相关论文
共 50 条
  • [1] BEFLOCQ A, 1998, AM J PATHOL, V152, P83
  • [2] A western surgical experience of peripheral cholangiocarcinoma
    Berdah, SV
    Delpero, JR
    Garcia, S
    Hardwigsen, J
    LeTreut, YP
    [J]. BRITISH JOURNAL OF SURGERY, 1996, 83 (11) : 1517 - 1521
  • [3] Hepatic resection and transplantation for peripheral cholangiocarcinoma
    Casavilla, FA
    Marsh, JW
    Iwatsuki, S
    Todo, S
    Lee, RG
    Madariaga, JR
    Pinna, A
    Dvorchik, I
    Fung, JJ
    Starzl, TE
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1997, 185 (05) : 429 - 436
  • [4] CHU K, 2005, WORLD J SURG, V21, P301
  • [5] Intrahepatic cholangiocarcinoma
    Chu, KM
    Lai, ECS
    AlHadeedi, S
    Arcilla, CE
    Lo, CM
    Liu, CL
    Fan, ST
    Wong, J
    [J]. WORLD JOURNAL OF SURGERY, 1997, 21 (03) : 301 - 306
  • [6] COUINAUD C, 1954, PRESSE MED, V62, P709
  • [7] Inflammation and cancer
    Coussens, LM
    Werb, Z
    [J]. NATURE, 2002, 420 (6917) : 860 - 867
  • [8] Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention
    Duffy, BK
    Gurm, HS
    Rajagopal, V
    Gupta, R
    Ellis, SG
    Bhatt, DL
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (07) : 993 - 996
  • [9] p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer
    Fondevila, C
    Metges, JP
    Fuster, J
    Grau, JJ
    Palacín, A
    Castells, A
    Volant, A
    Pera, M
    [J]. BRITISH JOURNAL OF CANCER, 2004, 90 (01) : 206 - 215
  • [10] A prospective study of serum C-reactive protein and colorectal cancer risk in men
    Gunter, MJ
    Stolzenberg-Solomon, R
    Cross, AJ
    Leitzmann, MF
    Weinstein, S
    Wood, RJ
    Virtamo, J
    Taylor, PR
    Albanes, D
    Sinha, R
    [J]. CANCER RESEARCH, 2006, 66 (04) : 2483 - 2487